IRCT20230314057712N1招募中4 期
Comparison of efficacy and safety of empagliflozin with placebo in patients with idiopathic edema
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients over 18 years of age who refer due to generalized edema
- •The patient does not take drugs that cause edema
- •In the diagnostic investigations, there are no disorders, including kidney, heart, liver, thyroid, etc. There should be no justification and cause of generalized edema for the patient
排除标准
- •Patients who do not want to cooperate and participate in the research
- •Patients with diseases such as advanced renal failure, liver failure, chronic or recurrent UTI
- •Patients with immune deficiency or diabetes
- •Patients who use drugs that interfere with the intervention process
研究者
相似试验
尚未招募
3 期
Comparison of therapeutic effect of Empagliflozin (Gloripa) and Sitagliptin (Ziptin) on type 2 Diabetic patientsIRCT20200810048355N1Vice Chancellor for Research, Islamic Aazad University, Najafabad branch128
招募中
3 期
Evaluation of the effectiveness of Empagliflozin on metabolic factors and liver function testsIRCT20191209045671N3Semnan University of Medical Sciences60
招募中
3 期
Effect of Empagliflozin in PrediabetesCondition 1: Impaired fasting glucose. Condition 2: Impaired glucose tolerance.Impaired fasting glucoseImpaired glucose tolerance (oral)R73.01R73.02IRCT20220902055858N1Shahre-kord University of Medical Sciences90
尚未招募
4 期
Efficacy and Safety of empagliflozin in patients with hepatic ascites: a randomized controlled trialDigestive SystemPACTR202402866059449one60
尚未招募
3 期
Assessment of effectiveness of Empagliflozin in the management of Anemia in diabetes patientsCTRI/2024/02/063292SRM Insitute of Science and Technology